Why Goldman Sachs has added Edwards Lifesciences to its June US Conviction List
Latest selections add five and cut four stocksMedical kit maker seen as an attractive option, Goldman saysReturns on capital and equity at 17.8% and 21.6%On Monday (3 Jun), analysts at investment bank Goldman Sachs did their monthly rejig of their US Conviction List, a curated selection of stocks the firm believes will outperform over the coming months.Five stocks were added this time round, inclu